Organisation paid for research Program year 2021 Source: CMS Open Payments

Translational Research Group Inc

Neither a doctor nor a teaching hospital

Research payments

$560,897

33 payments

Through program year 2021, Translational Research Group Inc is reported as receiving $560,897 in research payments, across 33 payments.

By program year

3 rows
Year Kind Amount Payments
2021 Research $233,344 3
2020 Research $315,687 21
2019 Research $11,866 9

Breakdown

Who paid Research payments · program years 2019–2021
  1. AbbVie, Inc. $538,609 17 payments
  2. Regeneron Pharmaceuticals, Inc. $19,846 13 payments
  3. Pfizer Inc. $2,441 3 payments
Studies the money was for Research payments · program years 2019–2021
  1. M17-238 $305,266 14 payments
  2. A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-157 in Healthy Volunteers and in Subjects with Chronic Plaque Psoriasis $233,344 3 payments
  3. A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Praluent on Neurocognitive Function in Patients With Heterozygous Familial Hypercholesterolemia or With Non-Familial Hypercholesterolemia at High and Very High Cardiovascular Risk $8,350 7 payments
  4. A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Praluent on Neurocognitive Function in Patients With Heterozygous Familial Hypercholesterolemia Or With Non-Familial Hypercholesterolemia at High and Very High Cardiovascular Risk $7,980 4 payments
  5. A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fasinumab in Patients With Moderate-To-Severe Chronic Low Back Pain and Osteoarthritis of the Hip Or Knee $3,515 2 payments
  6. A Phase 3 Randomized Doubleblind Placebocontrolled 26Week Multicenter Study With A 78Week Extension to Evaluate the Efficacy and Safety of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control on Metformin Mo $2,441 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record